Skip to main content
Csm Bradke header 498bf3128b

News categories: Honors & Funding

Frank Bradke receives the 50,000 Euro Academy Prize

Neurobiologist Frank Bradke, a research group leader at DZNE and professor at the University of Bonn, has been awarded the 50,000 euro Academy Prize of the Berlin-Brandenburg Academy of Sciences and Humanities. The award recognizes his outstanding scientific accomplishments in the field of neuronal development and regeneration. With his studies, the Bonn scientist, who focuses on fundamental mechanisms, aims to pave the way for a better treatment of spinal cord injuries. In recent years, Bradke has already been recognized with several awards for his exceptional research.

The nerve fibers in the spinal cord cannot regenerate. Thus, if they are damaged or even severed, this can result in permanent paralysis or have other serious outcomes. In light of this, Frank Bradke and his research team are investigating how neurons grow and whether it is possible to specifically activate this growth after neuronal damage. To this end, the Bonn researchers carry out studies on cell cultures as well as in mice and rats. Over the years they discovered, for example, how the cytoskeleton is involved in neuronal growth and also gained key insights into the mechanisms that prevent the regrowth respectively regeneration of neurons after damage.

“I am thrilled to receive this award. It is an extraordinary honor for me personally, but also a great recognition for the entire team from our lab. Because fundamental research, as we do it, is a team effort,” says Bradke.

The Academy Prize of the Berlin-Brandenburg Academy of Sciences and Humanities is awarded for outstanding scientific achievements in any disciplinary field and can be conferred every two years. On this occasion, it will be presented at a ceremony in Berlin on June 15.

Interview:

Also check out Frank Bradke's interview on spinal cord injuries

Press contact:

Dr. Markus Neitzert

E-Mail: markus.neitzert@dzne.de

Related news

Prof. Dr. Frank G. Holz – Director of the Department of Ophthalmology at the University Hospital Bonn (UKB) and Professor at the University of Bonn.

News categories: Honors & Funding

Frank Holz Nominated for the Science Breakthrough of the Year 2026

A remarkable achievement for the Faculty of Medicine at the University of Bonn: Prof. Dr. Frank G. Holz, Director of the Department of Ophthalmology at the UKB and Professor at the University of Bonn, has been shortlisted for the Falling Walls Science Breakthrough of the Year 2026 in the Life Sciences category. His project is now among the 30 most outstanding scientific innovations worldwide in this category, recognized by the prestigious Falling Walls Science Summit. Being shortlisted alone represents a significant international distinction.
View entry
Prof. Dr. Elvira Mass (left) and Prof. Dr. Tatjana Tchumatchenko (right)

News categories: Honors & Funding

Hunting for New Angles

New research questions often arise where different methods, mindsets and subject-specific cultures meet, and it is these kinds of encounter that Professor Elvira Mass and Professor Tatjana Tchumatchenko want to make happen in a targeted way in future. The two researchers have been picked as Henriette Herz Scouts by the Alexander von Humboldt Foundation.
View entry
Precise Konsortium

News categories: Publication Honors & Funding

Making Cancer Cells More Predictable: PRECISE Aims to Forecast Therapeutically Actionable Vulnerabilities

Which genes and signaling pathways does a cancer cell require to survive? And which of these could serve as therapeutic targets? The pan-European initiative PRECISE aims to identify such vulnerabilities not only through labor-intensive laboratory experiments but also by predicting them using computational models. The UKB and the University of Bonn, represented by Prof. Dr. Maximilian Billmann and Prof. Dr. Jonathan Schmid-Burgk, are among the founding partners of the consortium. The scientific vision of the initiative has now been published in a commentary in Nature Genetics.
View entry

Back to the news overview